• Haptoglobin Genotyping
  • Creatinine Random, Urine
  • Parathyroid Hormone (PTH), Intact
  • Neurotrophic Receptor Tyrosine Kinase 1 (NTRK1) Gene Mutation Analysis (Translocation)
  • Syphilis, tertiary
  • Dementia
  • FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • Zinc, Serum
  • Electrolyte Panel, Serum
  • Aspartate Aminotransferase (AST)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection
Medical Test

Additional Testing
Access to OncoTarget™ and OncoTreat™ Test for Cancer Therapy Selection is restricted.
Loading...